High Hemoglobin: Causes and Risks

Elevated hemoglobin almost always needs to be considered in conjunction with hematocrit and red blood cell count. Elevated hemoglobin alone is not a disease in itself. It is a laboratory finding that can indicate either an actual increase in red blood cell mass or a decrease in plasma volume, as the blood becomes more concentrated. This is why modern hematology uses the more precise term erythrocytosis. [1]

Erythrocytosis is divided into relative and absolute. Relative erythrocytosis occurs when the actual number of red blood cells has not increased, but the plasma volume has decreased. This occurs with dehydration, fluid loss through the gastrointestinal tract, diuretic use, and some types of hemoconcentration. Absolute erythrocytosis means that the bone marrow is actually producing too many red blood cells. [2]

Absolute erythrocytosis, in turn, can be primary or secondary. Primary erythrocytosis is associated with autonomous, i.e., independent of external stimuli, red blood cell production in the bone marrow. A classic example is polycythemia vera, a myeloproliferative neoplasm almost always associated with a variant of the JAK2 gene. Secondary erythrocytosis is the body's response to elevated erythropoietin levels or hypoxia. [3]

In practice, this distinction is crucial. True polycythemia is associated with a high risk of arterial and venous thrombosis, bleeding, myelofibrosis, and acute myeloid leukemia. Secondary erythrocytosis is more often a consequence of another disease or an external factor, rather than an independent malignant bone marrow pathology. Therefore, equally high hemoglobin levels in two different people can indicate completely different clinical situations. [4]

Another important point is that secondary erythrocytosis is more common than polycythemia vera. A Canadian review indicates that secondary erythrocytosis is observed in 6%-8% of patients with chronic obstructive pulmonary disease and in 2%-8% of patients with obstructive sleep apnea, while polycythemia vera remains rare. Therefore, the first detection of high hemoglobin should not automatically assume myeloproliferative disease. [5]

Table 1. Main options for increasing hemoglobin

Option	What's happening	Typical examples
Relative erythrocytosis	The number of red blood cells did not increase, but the plasma decreased.	Dehydration, diuretics, hemoconcentration
Absolute primary erythrocytosis	Bone marrow produces red blood cells autonomously	Polycythemia vera
Absolute secondary erythrocytosis	Red blood cells grow in response to erythropoietin or hypoxia	Chronic hypoxia, smoking, testosterone, kidney tumors

The table summarizes the modern division of erythrocytosis into relative, primary and secondary. [6]

Causes of elevated hemoglobin: from dehydration to polycythemia vera

The simplest and most common cause of a temporary increase in hemoglobin is a decrease in plasma volume. This occurs with dehydration, intense sweating, fever, diarrhea, vomiting, and the use of diuretics. In such situations, the red blood cell count may appear high, although the problem is actually related to blood concentration, not true excessive erythropoiesis. [7]

Among the secondary causes, chronic hypoxia plays a key role. The body perceives a lack of oxygen as a signal to increase erythropoietin production and red blood cell count. This can occur in chronic obstructive pulmonary disease, congenital heart defects with right-to-left shunting, living at high altitudes, chronic respiratory failure, and some other conditions. Smoking is also a contributing factor, as carboxyhemoglobin impairs oxygen delivery to tissues. [8]

Obstructive sleep apnea is often discussed as a cause of secondary erythrocytosis, but caution is needed. Modern reviews confirm the link between sleep apnea and erythrocytosis, but newer data show that many patients have normal hematocrit levels, and clinically significant secondary erythrocytosis does not develop in all patients. This is an important detail, as it prevents any high hemoglobin level from being attributed solely to nocturnal snoring. [9]

A separate group of causes is drug-induced erythrocytosis. The most common medications are testosterone and exogenous erythropoietin. A 2025 systematic review specifically highlighted that sodium-glucose cotransporter-2 inhibitors are also becoming an increasingly prominent cause. Therefore, with high hemoglobin, a complete medication history is essential, including hormones, sports medications, and modern cardiometabolic agents. [10]

Finally, there is primary clonal erythrocytosis—polycythemia vera—and rare congenital forms. Congenital erythrocytosis is particularly characterized by a long history from a young age, familial cases, and the absence of a JAK2 mutation. Mayo Clinic Laboratories and MedlinePlus Genetics indicate that in such situations, high-affinity hemoglobin variants and mutations in the EPOR, VHL, EGLN1, EPAS1, and BPGM genes should be considered. [11]

Table 2. Common causes of elevated hemoglobin

Group of reasons	Examples
Relative erythrocytosis	Dehydration, diuretics, fluid loss
Hypoxic secondary erythrocytosis	Chronic lung disease, altitude, smoking, congenital heart defects
Drug-induced secondary erythrocytosis	Testosterone, erythropoietin, sodium-glucose cotransporter-2 inhibitors
Tumor secondary erythrocytosis	Erythropoietin-producing tumors of the kidney and liver
Primary erythrocytosis	Polycythemia vera
Congenital erythrocytosis	High affinity hemoglobins, mutations EPOR, VHL, EGLN1, EPAS1, BPGM

The table is based on reviews of erythrocytosis diagnostics, materials from Mayo Clinic Laboratories and MedlinePlus Genetics. [12]

Symptoms, risks, and warning signs

Not every person with high hemoglobin has any complaints. But when symptoms do occur, they are often associated with increased blood viscosity and impaired microcirculation. The UK National Health Service and MedlinePlus list headache, dizziness, fatigue, blurred vision, tinnitus, facial flushing, and itching, especially after a warm shower or bath, as typical symptoms. [13]

Polycythemia vera often also presents with more characteristic symptoms, such as a feeling of fullness in the left hypochondrium due to an enlarged spleen, erythromelalgia (a burning pain and redness of the hands or feet), and microvascular symptoms. This combination is particularly important because it makes a clonal blood disorder more likely than simple hemoconcentration or mild secondary erythrocytosis. [14]

The main risk is thrombosis. A high red blood cell mass increases blood viscosity and impairs blood flow through the vessels. In polycythemia vera, this leads to a significantly increased risk of both arterial and venous thrombosis, including unusual locations such as splanchnic veins. A 2025 review indicated that by the time of diagnosis, arterial thrombosis had already occurred in 16% of patients, and venous thrombosis in 7%. [15]

However, it is important not to automatically transfer this risk to any secondary erythrocytosis. The Canadian review and British guidelines emphasize that there is no convincing evidence of the same sustained increase in thromboembolic risk for secondary erythrocytosis as in polycythemia vera, so routine therapy based on the myeloproliferative disease model is not appropriate. This is one of the most important contemporary clinical nuances. [16]

Signs of thrombosis or acute ischemia require urgent medical attention: pain and swelling of the leg, sudden shortness of breath, chest pain, hemoptysis, weakness in the arm or leg, sudden speech impairment, severe headache, or symptoms of a stroke. The UK National Health Service clearly states that erythrocytosis increases the risk of blood clots, heart attack, and stroke, and these conditions require urgent care. [17]

Table 3. Symptoms and red flags of elevated hemoglobin

Sign	What could it mean?
Headache, dizziness, blurred vision	Increased blood viscosity and impaired microcirculation
Itchy skin after warm water	Particularly typical for true polycythemia
Redness of the face, hands, feet	Microvascular disorders are possible
Fullness in the left hypochondrium	Possible enlargement of the spleen
Pain and swelling in the leg, sudden shortness of breath, chest pain	Possible venous thrombosis or thromboembolism
Speech impairment, weakness, severe neurological symptoms	Possible stroke

The table summarizes the symptoms of erythrocytosis and thrombotic red flags from NHS, MedlinePlus and reviews of polycythaemia vera.[18]

Diagnosis: How doctors determine the cause step by step

The first step is to confirm that the abnormality is indeed persistent. A repeat complete blood count should preferably be performed after normal hydration and without strenuous physical activity the previous day. Not only hemoglobin, but also hematocrit, red blood cell count, white blood cell count, platelet count, and ferritin are assessed. This is important because leukocytosis, thrombocytosis, and iron deficiency are often also detected in polycythemia vera. [19]

During the interview and examination, the physician first attempts to rule out relative erythrocytosis and then distinguish between primary and secondary variants. This requires questions about smoking, diuretics, testosterone, erythropoietin, new cardiometabolic medications, symptoms of sleep apnea, chronic dyspnea, congenital heart defects, living at altitude, and family history of erythrocytosis. This focused history remains the basis for diagnosis. [20]

Hypoxia is then assessed. Pulse oximetry below 92% in room air suggests a hypoxic cardiopulmonary mechanism. However, there are pitfalls here too: with sleep apnea, high-affinity hemoglobin, and carboxyhemoglobinemia, oxygen saturation may be normal or falsely reassuring. Therefore, normal pulse oximetry does not completely resolve the issue. [21]

Key laboratory tests for distinguishing between primary and secondary erythrocytosis are erythropoietin levels and JAK2 mutation testing. Low erythropoietin levels support the diagnosis of polycythemia vera, while high levels support the diagnosis of secondary erythrocytosis. In a Canadian review, erythropoietin levels below 2.9 international units per milliliter had a 92% specificity for polycythemia vera, while levels above 15.1 international units per milliliter had a 98% specificity for secondary erythrocytosis. If the likelihood of polycythemia vera is high, some clinicians administer erythropoietin and JAK2 simultaneously.[22]

If the JAK2 V617F mutation is not detected and erythropoietin remains low or normal, the next steps typically include searching for the JAK2 mutation in exon 12 and bone marrow examination. If secondary causes have already been excluded and the history is long-standing or familial, hereditary forms and more in-depth genetic testing for high-affinity hemoglobins and mutations in EPOR, VHL, EGLN1, EPAS1, and BPGM are considered. [23]

The diagnostic thresholds for suspected polycythemia vera in modern reviews are: hemoglobin above 165 grams per liter or hematocrit above 49% in men, and hemoglobin above 160 grams per liter or hematocrit above 48% in women, combined with the JAK2 mutation. However, these numbers should not be used as a generic label, "anything above that is blood cancer." They exist for specialized diagnostics and only work in the context of the whole picture. [24]

Table 4. Step-by-step algorithm for persistently elevated hemoglobin

Step	What is being assessed?	Why is this necessary?
1	Repeat complete blood count after normal hydration	Confirm the persistence of the deviation
2	Hematocrit, erythrocytes, leukocytes, platelets, ferritin	To see a pattern that is typical or atypical for polycythemia vera
3	Smoking, medications, testosterone, erythropoietin, sleep apnea symptoms, altitude	Find common secondary causes
4	Pulse oximetry and, if indicated, night oximetry, blood gas composition, carboxyhemoglobin	Assess hypoxia
5	Erythropoietin and JAK2 mutation	Distinguish between primary and secondary erythrocytosis
6	Bone marrow, kidney and liver imaging, genetic testing as indicated	Clarify rare and complex causes

The table is based on reviews of erythrocytosis diagnostics, Mayo Clinic Laboratories data, and current updates on polycythemia vera.[25]

Table 5. How true polycythemia differs from secondary erythrocytosis

Sign	Polycythemia vera	Secondary erythrocytosis
Mechanism	Clonal myeloproliferative disorder	Response to hypoxia or excess erythropoietin
JAK2 mutation	Almost always there is	Usually absent
Erythropoietin	Often reduced	Often normal or elevated
Leukocytes and platelets	Often elevated	Typical panmyelosis is not usually present.
Thrombotic risk	Markedly elevated	Less defined and depends on the cause
Basic treatment	Aspirin, bloodletting, and, if the risk is high, cytoreduction	Treating the cause, not routine bloodletting

The table summarizes the differences between primary and secondary erythrocytosis according to current reviews and guidelines.[26]

Treatment: Why strategy depends not on the number, but on the cause

In cases of relative erythrocytosis, the source of hemoconcentration, rather than the bone marrow, is treated. This involves correcting dehydration, revising diuretics, avoiding excess alcohol, and eliminating factors that reduce plasma volume. Once hydration is normalized, parameters often return to normal levels without any hematological therapy. [27]

In secondary erythrocytosis, the primary principle remains treatment of the underlying cause. A Canadian review explicitly states that routine phlebotomy is not recommended for secondary erythrocytosis because there is no convincing evidence of a consistent increase in thromboembolic risk. This means that treatment should be aimed at correcting hypoxia, smoking cessation, medication revision, or treating the erythropoietin-producing tumor, rather than automatically lowering the hematocrit at any cost. [28]

For some causes, there are specific tactical solutions. In hypoxic lung disease, long-term oxygen therapy may be required. For testosterone-induced erythrocytosis, British and Canadian guidelines recommend stopping testosterone if the hematocrit level rises moderately or severely and reintroducing it only after normalization, and at a lower dose. For erythrocytosis after kidney transplantation, an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker may be used. [29]

Polycythemia vera is treated differently. A 2025 review in the Journal of the American Medical Association emphasizes that all patients, unless contraindicated, are treated with low-dose aspirin and therapeutic phlebotomy to maintain hematocrit below 45%. Patients aged 60 years and older or with a history of thrombosis are considered high-risk and, in addition, typically require cytoreductive therapy, most often hydroxyurea or interferon. Ruxolitinib is considered in cases of resistance to or intolerance to hydroxyurea. [30]

It's crucial not to generalize the approach to polycythemia vera to all other conditions. In a patient with sleep apnea, smoking, or testosterone, high hemoglobin levels do not always require the same strategy as a myeloproliferative neoplasm. This is why safe treatment begins not with bloodletting, but with a correct diagnosis. [31]

Table 6. Treatment of elevated hemoglobin depending on the cause

Cause	The basic approach
Relative erythrocytosis	Rehydration and elimination of hemoconcentration
Hypoxic secondary erythrocytosis	Treatment of hypoxia and the underlying disease
Smoking and carboxyhemoglobinemia	Smoking cessation and exposure reduction
Testosterone-induced erythrocytosis	Cancellation or reduction of testosterone dose as indicated
Tumor secondary erythrocytosis	Tumor treatment and causes of excess erythropoietin
Polycythemia vera	Low doses of aspirin, bloodletting to hematocrit below 45%, with a high risk of cytoreduction

The table summarizes the current principles of treatment of relative, secondary and primary erythrocytosis. [32]

Conclusion

Elevated hemoglobin is not a diagnosis, but a signal that requires proper interpretation. In one person, it may indicate normal hemoconcentration following fluid loss; in another, it may be a consequence of smoking, hypoxia, or testosterone; and in another, it may indicate true polycythemia with a real thrombotic risk. Therefore, it is important to evaluate not only the number but also the mechanism by which it occurs. [33]

The safest modern approach is to first confirm the persistence of the abnormality, then differentiate relative from absolute erythrocytosis, then differentiate primary and secondary variants using history, saturation, erythropoietin, and JAK2 mutation, and only then select treatment. This algorithm reduces the risk of both missing a myeloproliferative disorder and initiating unnecessary treatment where the underlying cause simply needs to be addressed. [34]

FAQ

Does high hemoglobin always indicate a blood disorder?
No. High hemoglobin can be a consequence of dehydration and decreased plasma volume, rather than a true increase in red blood cell mass. It can also be a secondary response to hypoxia, medications, or excess erythropoietin. [35]

How does high hemoglobin differ from polycythemia vera?
Polycythemia vera is a clonal myeloproliferative disorder, almost always associated with a JAK2 mutation. High hemoglobin is merely a laboratory finding that can also occur in many other conditions. [36]

When should you consider dehydration rather than bone marrow disease?
When the increase appears due to fluid loss, diuretics, heat, intense sweating, vomiting, or diarrhea, and the levels decrease after normal hydration. This is typical of relative erythrocytosis. [37]

Can smoking increase hemoglobin levels?
Yes. Smoking increases carboxyhemoglobin and creates tissue hypoxia, which can stimulate erythropoiesis and lead to secondary erythrocytosis. [38]

Could sleep apnea be the sole cause of high hemoglobin?
It may, but it's not the most common or universal scenario. Sleep apnea is associated with higher hematocrit, but not all patients develop clinically significant secondary erythrocytosis. [39]

What are the most important tests after a repeat complete blood count?
The most important are hematocrit, ferritin, erythropoietin levels, JAK2 mutation testing, oxygen saturation assessment, and, if indicated, hypoxia testing, carboxyhemoglobin, kidney and liver imaging, and bone marrow. [40]

Do all people with high hemoglobin require phlebotomy?
No. Routine phlebotomy is not generally recommended for secondary erythrocytosis. This is the standard approach primarily for polycythemia vera, where the goal is to maintain the hematocrit below 45%. [41]

What medications are particularly common in causing secondary erythrocytosis?
Classically, these are testosterone and exogenous erythropoietin. The role of sodium-glucose cotransporter-2 inhibitors is also increasingly being described. [42]

When should you seek urgent medical attention?
Urgent medical attention is needed if you experience signs of thrombosis, pulmonary embolism, heart attack, or stroke: leg pain and swelling, sudden shortness of breath, chest pain, hemoptysis, limb weakness, speech impairment, or sudden severe neurological symptoms. [43]